000 | 01369 a2200397 4500 | ||
---|---|---|---|
005 | 20250513184523.0 | ||
264 | 0 | _c19990630 | |
008 | 199906s 0 0 eng d | ||
022 | _a0008-543X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKahán, Z | |
245 | 0 | 0 |
_aComplete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207. _h[electronic resource] |
260 |
_bCancer _cJun 1999 |
||
300 |
_a2608-15 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
650 | 0 | 4 |
_aDoxorubicin _xanalogs & derivatives |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xanalogs & derivatives |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 |
_aReceptors, LHRH _xdrug effects |
650 | 0 | 4 | _aTransplantation, Heterologous |
700 | 1 | _aNagy, A | |
700 | 1 | _aSchally, A V | |
700 | 1 | _aHalmos, G | |
700 | 1 | _aArencibia, J M | |
700 | 1 | _aGroot, K | |
773 | 0 |
_tCancer _gvol. 85 _gno. 12 _gp. 2608-15 |
|
999 |
_c10333574 _d10333574 |